 | • レポートコード：QYR2104Z3287 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、虚血性脳卒中治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（組織プラスミノーゲン活性化因子、抗凝固薬、抗血小板薬、降圧薬、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・虚血性脳卒中治療薬の市場動向 ・企業の競争状況、市場シェア ・虚血性脳卒中治療薬の種類別市場規模（組織プラスミノーゲン活性化因子、抗凝固薬、抗血小板薬、降圧薬、その他） ・虚血性脳卒中治療薬の用途別市場規模（病院、クリニック、外来手術センター、その他） ・虚血性脳卒中治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・虚血性脳卒中治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・虚血性脳卒中治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・虚血性脳卒中治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・虚血性脳卒中治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Merck、Boehringer Ingelheim、Sanofi、Johnson & Johnson、Bayer、Biogen、Abbott Laboratories、Genentech、Daiichi Sankyo） ・結論 |
Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.
Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.
Market Analysis and Insights: Global Ischemic Stroke Drugs Market
The global Ischemic Stroke Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ischemic Stroke Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ischemic Stroke Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ischemic Stroke Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ischemic Stroke Drugs market.
Global Ischemic Stroke Drugs Scope and Market Size
Ischemic Stroke Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ischemic Stroke Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Merck
Boehringer Ingelheim
Sanofi
Johnson & Johnson
Bayer
Biogen
Abbott Laboratories
Genentech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ischemic Stroke Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tissue Plasminogen Activator
1.2.3 Anticoagulant
1.2.4 Antiplatelet
1.2.5 Antihypertensive
1.2.6 Others
1.3 Market by Application
1.3.1 Global Ischemic Stroke Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ischemic Stroke Drugs Market Perspective (2016-2027)
2.2 Ischemic Stroke Drugs Growth Trends by Regions
2.2.1 Ischemic Stroke Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ischemic Stroke Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Ischemic Stroke Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Ischemic Stroke Drugs Industry Dynamic
2.3.1 Ischemic Stroke Drugs Market Trends
2.3.2 Ischemic Stroke Drugs Market Drivers
2.3.3 Ischemic Stroke Drugs Market Challenges
2.3.4 Ischemic Stroke Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ischemic Stroke Drugs Players by Revenue
3.1.1 Global Top Ischemic Stroke Drugs Players by Revenue (2016-2021)
3.1.2 Global Ischemic Stroke Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Ischemic Stroke Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ischemic Stroke Drugs Revenue
3.4 Global Ischemic Stroke Drugs Market Concentration Ratio
3.4.1 Global Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ischemic Stroke Drugs Revenue in 2020
3.5 Ischemic Stroke Drugs Key Players Head office and Area Served
3.6 Key Players Ischemic Stroke Drugs Product Solution and Service
3.7 Date of Enter into Ischemic Stroke Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ischemic Stroke Drugs Breakdown Data by Type
4.1 Global Ischemic Stroke Drugs Historic Market Size by Type (2016-2021)
4.2 Global Ischemic Stroke Drugs Forecasted Market Size by Type (2022-2027)
5 Ischemic Stroke Drugs Breakdown Data by Application
5.1 Global Ischemic Stroke Drugs Historic Market Size by Application (2016-2021)
5.2 Global Ischemic Stroke Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Ischemic Stroke Drugs Market Size (2016-2027)
6.2 North America Ischemic Stroke Drugs Market Size by Type
6.2.1 North America Ischemic Stroke Drugs Market Size by Type (2016-2021)
6.2.2 North America Ischemic Stroke Drugs Market Size by Type (2022-2027)
6.2.3 North America Ischemic Stroke Drugs Market Size by Type (2016-2027)
6.3 North America Ischemic Stroke Drugs Market Size by Application
6.3.1 North America Ischemic Stroke Drugs Market Size by Application (2016-2021)
6.3.2 North America Ischemic Stroke Drugs Market Size by Application (2022-2027)
6.3.3 North America Ischemic Stroke Drugs Market Size by Application (2016-2027)
6.4 North America Ischemic Stroke Drugs Market Size by Country
6.4.1 North America Ischemic Stroke Drugs Market Size by Country (2016-2021)
6.4.2 North America Ischemic Stroke Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Ischemic Stroke Drugs Market Size (2016-2027)
7.2 Europe Ischemic Stroke Drugs Market Size by Type
7.2.1 Europe Ischemic Stroke Drugs Market Size by Type (2016-2021)
7.2.2 Europe Ischemic Stroke Drugs Market Size by Type (2022-2027)
7.2.3 Europe Ischemic Stroke Drugs Market Size by Type (2016-2027)
7.3 Europe Ischemic Stroke Drugs Market Size by Application
7.3.1 Europe Ischemic Stroke Drugs Market Size by Application (2016-2021)
7.3.2 Europe Ischemic Stroke Drugs Market Size by Application (2022-2027)
7.3.3 Europe Ischemic Stroke Drugs Market Size by Application (2016-2027)
7.4 Europe Ischemic Stroke Drugs Market Size by Country
7.4.1 Europe Ischemic Stroke Drugs Market Size by Country (2016-2021)
7.4.2 Europe Ischemic Stroke Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Ischemic Stroke Drugs Market Size (2016-2027)
8.2 Asia-Pacific Ischemic Stroke Drugs Market Size by Type
8.2.1 Asia-Pacific Ischemic Stroke Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ischemic Stroke Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ischemic Stroke Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Ischemic Stroke Drugs Market Size by Application
8.3.1 Asia-Pacific Ischemic Stroke Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ischemic Stroke Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ischemic Stroke Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Ischemic Stroke Drugs Market Size by Region
8.4.1 Asia-Pacific Ischemic Stroke Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ischemic Stroke Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ischemic Stroke Drugs Market Size (2016-2027)
9.2 Latin America Ischemic Stroke Drugs Market Size by Type
9.2.1 Latin America Ischemic Stroke Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Ischemic Stroke Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Ischemic Stroke Drugs Market Size by Type (2016-2027)
9.3 Latin America Ischemic Stroke Drugs Market Size by Application
9.3.1 Latin America Ischemic Stroke Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Ischemic Stroke Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Ischemic Stroke Drugs Market Size by Application (2016-2027)
9.4 Latin America Ischemic Stroke Drugs Market Size by Country
9.4.1 Latin America Ischemic Stroke Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Ischemic Stroke Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ischemic Stroke Drugs Market Size (2016-2027)
10.2 Middle East & Africa Ischemic Stroke Drugs Market Size by Type
10.2.1 Middle East & Africa Ischemic Stroke Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ischemic Stroke Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ischemic Stroke Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Ischemic Stroke Drugs Market Size by Application
10.3.1 Middle East & Africa Ischemic Stroke Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ischemic Stroke Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ischemic Stroke Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Ischemic Stroke Drugs Market Size by Country
10.4.1 Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Ischemic Stroke Drugs Introduction
11.1.4 Pfizer Revenue in Ischemic Stroke Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Ischemic Stroke Drugs Introduction
11.2.4 Merck Revenue in Ischemic Stroke Drugs Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Ischemic Stroke Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Ischemic Stroke Drugs Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Ischemic Stroke Drugs Introduction
11.4.4 Sanofi Revenue in Ischemic Stroke Drugs Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Ischemic Stroke Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Ischemic Stroke Drugs Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Ischemic Stroke Drugs Introduction
11.6.4 Bayer Revenue in Ischemic Stroke Drugs Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Biogen
11.7.1 Biogen Company Details
11.7.2 Biogen Business Overview
11.7.3 Biogen Ischemic Stroke Drugs Introduction
11.7.4 Biogen Revenue in Ischemic Stroke Drugs Business (2016-2021)
11.7.5 Biogen Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Ischemic Stroke Drugs Introduction
11.8.4 Abbott Laboratories Revenue in Ischemic Stroke Drugs Business (2016-2021)
11.8.5 Abbott Laboratories Recent Development
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Genentech Business Overview
11.9.3 Genentech Ischemic Stroke Drugs Introduction
11.9.4 Genentech Revenue in Ischemic Stroke Drugs Business (2016-2021)
11.9.5 Genentech Recent Development
11.10 Daiichi Sankyo
11.10.1 Daiichi Sankyo Company Details
11.10.2 Daiichi Sankyo Business Overview
11.10.3 Daiichi Sankyo Ischemic Stroke Drugs Introduction
11.10.4 Daiichi Sankyo Revenue in Ischemic Stroke Drugs Business (2016-2021)
11.10.5 Daiichi Sankyo Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Ischemic Stroke Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tissue Plasminogen Activator
Table 3. Key Players of Anticoagulant
Table 4. Key Players of Antiplatelet
Table 5. Key Players of Antihypertensive
Table 6. Key Players of Others
Table 7. Global Ischemic Stroke Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Ischemic Stroke Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Ischemic Stroke Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Ischemic Stroke Drugs Market Share by Regions (2016-2021)
Table 11. Global Ischemic Stroke Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Ischemic Stroke Drugs Market Share by Regions (2022-2027)
Table 13. Ischemic Stroke Drugs Market Trends
Table 14. Ischemic Stroke Drugs Market Drivers
Table 15. Ischemic Stroke Drugs Market Challenges
Table 16. Ischemic Stroke Drugs Market Restraints
Table 17. Global Ischemic Stroke Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Ischemic Stroke Drugs Market Share by Players (2016-2021)
Table 19. Global Top Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ischemic Stroke Drugs as of 2020)
Table 20. Ranking of Global Top Ischemic Stroke Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Ischemic Stroke Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Ischemic Stroke Drugs Product Solution and Service
Table 24. Date of Enter into Ischemic Stroke Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Ischemic Stroke Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Ischemic Stroke Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Ischemic Stroke Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Ischemic Stroke Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Ischemic Stroke Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Ischemic Stroke Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Ischemic Stroke Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Ischemic Stroke Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Ischemic Stroke Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Ischemic Stroke Drugs Product
Table 67. Pfizer Revenue in Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Merck Company Details
Table 70. Merck Business Overview
Table 71. Merck Ischemic Stroke Drugs Product
Table 72. Merck Revenue in Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 73. Merck Recent Development
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Ischemic Stroke Drugs Product
Table 77. Boehringer Ingelheim Revenue in Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Development
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Ischemic Stroke Drugs Product
Table 82. Sanofi Revenue in Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 83. Sanofi Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Ischemic Stroke Drugs Product
Table 87. Johnson & Johnson Revenue in Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Ischemic Stroke Drugs Product
Table 92. Bayer Revenue in Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Biogen Company Details
Table 95. Biogen Business Overview
Table 96. Biogen Ischemic Stroke Drugs Product
Table 97. Biogen Revenue in Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 98. Biogen Recent Development
Table 99. Abbott Laboratories Company Details
Table 100. Abbott Laboratories Business Overview
Table 101. Abbott Laboratories Revenue in Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 102. Abbott Laboratories Recent Development
Table 103. Genentech Company Details
Table 104. Genentech Business Overview
Table 105. Genentech Ischemic Stroke Drugs Product
Table 106. Genentech Revenue in Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 107. Genentech Recent Development
Table 108. Daiichi Sankyo Company Details
Table 109. Daiichi Sankyo Business Overview
Table 110. Daiichi Sankyo Ischemic Stroke Drugs Product
Table 111. Daiichi Sankyo Revenue in Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 112. Daiichi Sankyo Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ischemic Stroke Drugs Market Share by Type: 2020 VS 2027
Figure 2. Tissue Plasminogen Activator Features
Figure 3. Anticoagulant Features
Figure 4. Antiplatelet Features
Figure 5. Antihypertensive Features
Figure 6. Others Features
Figure 7. Global Ischemic Stroke Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Ischemic Stroke Drugs Report Years Considered
Figure 13. Global Ischemic Stroke Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Ischemic Stroke Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Ischemic Stroke Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Ischemic Stroke Drugs Market Share by Regions (2022-2027)
Figure 17. Global Ischemic Stroke Drugs Market Share by Players in 2020
Figure 18. Global Top Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ischemic Stroke Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Ischemic Stroke Drugs Revenue in 2020
Figure 20. Global Ischemic Stroke Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Ischemic Stroke Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Ischemic Stroke Drugs Market Share by Type (2016-2027)
Figure 24. North America Ischemic Stroke Drugs Market Share by Application (2016-2027)
Figure 25. North America Ischemic Stroke Drugs Market Share by Country (2016-2027)
Figure 26. United States Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Ischemic Stroke Drugs Market Share by Type (2016-2027)
Figure 30. Europe Ischemic Stroke Drugs Market Share by Application (2016-2027)
Figure 31. Europe Ischemic Stroke Drugs Market Share by Country (2016-2027)
Figure 32. Germany Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Ischemic Stroke Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Ischemic Stroke Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Ischemic Stroke Drugs Market Share by Region (2016-2027)
Figure 42. China Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Ischemic Stroke Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Ischemic Stroke Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Ischemic Stroke Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Ischemic Stroke Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Ischemic Stroke Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Ischemic Stroke Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in Ischemic Stroke Drugs Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Ischemic Stroke Drugs Business (2016-2021)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Ischemic Stroke Drugs Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Ischemic Stroke Drugs Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Ischemic Stroke Drugs Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Ischemic Stroke Drugs Business (2016-2021)
Figure 67. Biogen Revenue Growth Rate in Ischemic Stroke Drugs Business (2016-2021)
Figure 68. Abbott Laboratories Revenue Growth Rate in Ischemic Stroke Drugs Business (2016-2021)
Figure 69. Genentech Revenue Growth Rate in Ischemic Stroke Drugs Business (2016-2021)
Figure 70. Daiichi Sankyo Revenue Growth Rate in Ischemic Stroke Drugs Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の虚血性脳卒中治療市場規模・現状・予測（2021年-2027年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Market Analysis and Insights: Global Ischemic S…- 世界の急性虚血性脳卒中診断・治療市場規模・現状・予測（2021年-2027年） According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. Market Analysis and Insights: Global Acute Ischemic Stroke Diagnosis and Treatment Market The global Acute Ischemic Stroke Diagnosis and Treatment market size is projected…
- 世界の急性虚血性脳卒中治療市場規模・現状・予測（2021年-2027年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…
- 世界の急性虚血性脳卒中治療市場規模・現状・予測（2021年-2027年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…
- 世界の脳卒中市場規模・現状・予測（2021年-2027年） Brain Stroke is one of the most common types of neurovascular disease in which either a clot blocks restricts supply of blood to the brain (ischemic) or blood vessels in the brain rupture (hemorrhagic). The vascular diseases affect normal functioning of the veins and arteries that constitute circula…